Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelly Joseph-Mathurin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Cell|September 27, 2024
CSF proteomics identifies early changes in autosomal dominant Alzheimer's diseaseYuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJulie K Wisch, Nicole S McKay, Matthew D Zammit, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 14, 2021
Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's diseaseOphir Keret, Adam M Staffaroni, John M Ringman, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Plos One|March 25, 2016
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Plos One|September 21, 2016
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupYi Su, Tyler M Blazey, Christopher J Owen, et al.
Cell|September 27, 2024
CSF proteomics identifies early changes in autosomal dominant Alzheimer's diseaseYuanyuan Shen, Jigyasha Timsina, Gyujin Heo, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersJulie K Wisch, Nicole S McKay, Matthew D Zammit, et al.
Neurobiology of Disease|June 12, 2020
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Jeremy F Strain, Adedamola Adedokun, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 14, 2021
Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's diseaseOphir Keret, Adam M Staffaroni, John M Ringman, et al.
Pageof 6